Research Article

Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway

Figure 6

A graphical summary for the cardioprotective effect of bardoxolone methyl (BARD) against myocardial I/R injury.